$16.53
00.00%
Last update: Sep 20, 4:03 PM
15 minutes delayed
ACADIA Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of ACADIA Pharmaceuticals using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-06 | $0.20 | $0.19 | 5.26 % |
Mar 2024 | 2024-05-08 | $0.10 | $0.05 | 100.0 % |
Dec 2023 | 2024-02-27 | $0.28 | $0.30 | -6.67 % |
Sep 2023 | 2023-11-02 | $-0.40 | $-0.43 | 6.98 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-06 | $241.96M | $236.00M | 2.53 % |
Mar 2024 | 2024-05-08 | $205.83M | $208.36M | -1.21 % |
Dec 2023 | 2024-02-27 | $231.04M | $223.70M | 3.28 % |
Sep 2023 | 2023-11-02 | $211.70M | $189.51M | 11.7 % |
ACADIA Pharmaceuticals (ACAD) is scheduled to report earnings on October 31, 2024. The last reported earnings were for reported on August 6, 2024 for Q2.
The Actual EPS was $0.20, which beat the estimate of $0.19.
The Actual Revenue was $242M, which beat the estimate of $236M.
Browse earnings estimates, EPS, and revenue on all stocks.